Financhill
Buy
57

WEX Quote, Financials, Valuation and Earnings

Last price:
$153.70
Seasonality move :
5.39%
Day range:
$150.55 - $155.14
52-week range:
$110.45 - $188.70
Dividend yield:
0%
P/E ratio:
19.98x
P/S ratio:
2.18x
P/B ratio:
4.72x
Volume:
267.8K
Avg. volume:
456.6K
1-year change:
-15.82%
Market cap:
$5.3B
Revenue:
$2.6B
EPS (TTM):
$7.70

Earnings Data

Next earnings date for WEX
Feb 04
2026
Most recent earnings per share
$2.31
Missed by $2.15
(Oct 29/2025)
Consensus Estimate
$4.45
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

WEX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $659.5M -- -- $3.90 --
10/29/2025 Q3 $679.9M $691.8M $2.31 $4.45 -$2.15
07/23/2025 Q2 $652M $659.6M $1.98 $3.71 -$1.73
04/30/2025 Q1 $632.5M $636.6M $1.81 $3.40 -$1.59
02/05/2025 Q4 $634.6M $636.5M $1.60 $3.55 -$1.95
10/24/2024 Q3 $686.4M $665.5M $2.52 $4.41 -$1.89
07/25/2024 Q2 $680M $673.5M $1.83 $3.81 -$1.97
04/25/2024 Q1 $654.9M $652.7M $1.55 $3.47 -$1.92
02/08/2024 Q4 $653.1M $663.3M $1.98 $3.72 -$1.73
10/26/2023 Q3 -- $651.4M $0.42 -- --
07/27/2023 Q2 -- $621.3M $2.20 -- --
04/27/2023 Q1 -- $612M $1.56 -- --
02/09/2023 Q4 -- $618.6M $2.02 -- --
10/27/2022 Q3 -- $616.1M -$1.00 -- --
07/28/2022 Q2 -- $598.2M $0.76 -- --
04/28/2022 Q1 -- $517.5M $2.71 -- --
02/10/2022 Q4 -- $497.5M -$0.26 -- --
10/28/2021 Q3 -- $482.8M $1.07 -- --
07/29/2021 Q2 -- $459.5M -$0.76 -- --
04/29/2021 Q1 -- $410.8M -$0.06 -- --
02/24/2021 Q4 -- $399M -$5.30 -- --
10/29/2020 Q3 -- $382.1M -$1.49 -- --
07/30/2020 Q2 -- $347.1M $1.66 -- --
05/07/2020 Q1 -- $431.7M -$0.37 -- --
02/13/2020 Q4 -- $440M $1.24 -- --
10/31/2019 Q3 -- $460M $0.33 -- --
08/01/2019 Q2 -- $441.8M $0.32 -- --
05/02/2019 Q1 -- $381.9M $0.37 -- --
03/18/2019 Q4 -- $381.2M $0.49 -- --
10/31/2018 Q3 -- $386.6M $1.30 -- --
08/02/2018 Q2 -- $370.8M $0.88 -- --
05/03/2018 Q1 -- $354M $1.20 -- --
02/21/2018 Q4 -- $331.6M $2.02 -- --
11/01/2017 Q3 -- $324M $0.79 -- --
07/27/2017 Q2 -- $303.9M $0.40 -- --
04/27/2017 Q1 -- $291.4M $0.68 -- --
02/13/2017 Q4 -- $290.8M $0.12 -- --
10/27/2016 Q3 -- $287.8M $0.46 -- --
07/27/2016 Q2 -- $233.9M $0.32 -- --
04/27/2016 Q1 -- $205.9M $0.59 -- --
02/08/2016 Q4 -- $212.6M $0.54 -- --

WEX, Inc. Earnings Questions

  • How Much did WEX, Inc. Generate in Revenue Last Quarter?

    WEX, Inc. reported $691.8M worth of top line sales in its most recent quarter.

  • Did WEX, Inc. Beat Earnings Last Quarter?

    WEX, Inc. announced earnings per share of $2.31 which represents a miss of analyst forecast a $4.45 per share.

  • Is WEX, Inc. Profitable?

    WEX, Inc. reported $393.2M that represents $11.30 per share over the last quarter.

  • What is the Analyst Consensus for WEX, Inc. EPS Next Year?

    WEX, Inc.'s earnings are forecast to grow from $7.50 per share to $15.93 per share next year representing an increase of 112.49%.

  • When is WEX, Inc.'s Earnings Date?

    WEX, Inc.'s next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock